Published in Gene Therapy Weekly, June 2nd, 2005
Study 1: Intraperitoneal antisense K-ras RNA suppresses pancreatic cancer dissemination.
According to researchers in Japan, "we examined the antitumor effect and safety of the adenovirus-mediated expression of antisense K-ras RNA in two peritoneal dissemination models of pancreatic cancer. First, we found that the infection of an adenovirus vector expressing antisense human K-ras RNA (AxCA-AS) induced significant apoptosis in vitro in human pancreatic cancer cells with K-ras mutation."
"Second, the intraperitoneal (i.p.) injection of AxCA-AS effectively suppressed the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-06-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.